Medtronic, Inc.

Other

Hologic, Inc.

Shifamed Holdings, LLC

Focal Therapeutics Inc.

Solinas Medical Inc.

Restoration Robotics, Inc.

Arbor Surgical Technologies, Inc.

Silicon Valley Innovations, Inc.

Intuitive Surgical Operations, Inc.

Thomas J. Fogarty

Varian Medical Systems, Inc.

Arstasis, Inc.

Michael J Drews

Thomas J Fogarty

D Bruce Modesitt

Neil D Holmgren

David B Willis

George D Hermann

Gail S Lebovic

Donnell William Gurskis

Ernest Lane

James B Stubbs

Robert T Chang

Richard S Lilly

James K Hong

Katherine Sapozhnikov

Eric Schultz

Claudio Argento

Steven Robert Bacich

Jonathan M Olson

Tom Saul

Takashi Harry Ino

Steven N Grolle

Dennis Westerling, Jr

Vahid Saadat

TOm Saul

Timothy J Kirkley

Stephen R Bacich

Neil Bruce Holmgren

Douglas S Sutton

Roger K Khouri

Roger A De La Torre

Thomas H Howell

David E Willis

Dwight John Knab, Jr

Bryan Wylie

Federico Gutierrez

Leslie Oley

Oleg Svanidze

Mimi Nguyen Fitterer

Federico Guiterrez

Jose De La Pena

Gail J Lebovic

Dwight J Knab

The present technology is directed to implantable medical devices for draining fluid from a first body region to a second body region. Some embodiments of the present technology provide adjustable devices that are selectively titratable to provide various levels of therapy. For example, the adjustable devices can have a drainage element with a lumen extending therethrough, a flow control element, and an actuation assembly. The actuation assembly can drive movement of the flow control element to change a dimension of and/or a flow resistance through the lumen, thereby increasing or decreasing the relative drainage rate of aqueous from an eye. In some embodiments, the actuation assembly and the flow control element together operate as a ratchet mechanism that can selectively move the flow control element between a plurality of positions and lock the device in a desired configuration until further actuation of the actuation assembly.

Adjustable glaucoma treatment devices and associated systems and methods

The present technology relates to intraocular shunting systems and methods. In some embodiments, the present technology includes intraocular shunting systems that include a drainage element having an inflow portion configured for placement within an anterior chamber of the eye outside of an optical field of view of the patient and an outflow portion configured for placement at a different location of the eye. The system can also include a flow control assembly having a rotational control element operably coupled to the drainage element. The flow control assembly can further include an actuation structure coupled to the rotational control element and configured to selectively change an orientation of the rotational control element. An amount of fluid through the inflow portion and/or the outflow portion can vary based on the selected orientation of the rotational control element.

Shunting systems with rotation-based flow control assemblies, and associated systems and methods

An implantable tissue marker device is provided to be placed in a soft tissue site through a surgical incision. The device can include a bioabsorbable body in the form of a spiral and defining a spheroid shape for the device, the spiral having a longitudinal axis, and turns of the spiral being spaced apart from each other in a direction along the longitudinal axis. A plurality of markers can be disposed on the body, the markers being visualizable by a radiographic imaging device. The turns of the spiral are sufficiently spaced apart to form gaps that allow soft tissue to infiltrate between the turns and to allow flexibility in the device along the longitudinal axis in the manner of a spring.

Surgical implant for marking soft tissue

Described herein are anatomical models for medical training, surgical planning, or patient demonstration. The anatomical models include a replica of a target body part that may be altered, unfinished, or deformed so that an anatomical component may be attached thereto to complete the replica and provide visual training with respect to symmetry and other aspects of medical or surgical procedures. For example, the anatomical models may be altered, unfinished, or deformed to simulate a post-surgical deformity. Systems and methods including the anatomical models are also described herein.

Oncoplastic surgery training model

The present technology is generally directed to adjustable shunting systems for draining fluid from a first body region to a second body region. The adjustable shunting systems include a flow control plate or cartridge for controlling the flow of fluid through the system. For example, the flow control plate can include a shape memory actuation assembly having one or more nitinol actuators for controlling the flow of fluid through the system. The flow control plate can further include a plurality of discrete sheets or layers adhered together to encase the shape memory actuation assembly. The discrete sheets or layers can form flow channels for directing fluid through the flow control plate.

Adjustable shunting systems with plate assemblies, and associated systems and methods

A self-closing device for implantation within a patient's body includes base material including an inner surface area for securing the base material to a tissue structure, and a plurality of support elements surrounding or embedded in the base material. The support elements are separable laterally within a plane of the base material to accommodate creating an opening through the base material for receiving one or more instruments through the base material, and biased to return laterally towards a relaxed state for self-closing the opening after removing the one or more instruments. The device may be provided as a patch or integrally attached to a tubular graft or in various shapes.

Self-closing devices and methods for making and using them

An implantable device has a body that is substantially rigid and has an imageable shape. The body is further bioabsorbable and may contain permanent metallic elements to aid in its imaging. When the device is implanted in a resected cavity in soft tissue, it can cause the cavity to conform substantially to a known imageable shape. The implantable device is further imageable due to its attenuation properties being different from those of soft tissue such that the boundaries of the tissue corresponding to the predetermined shape can be determined.

Diagnostic or therapeutic procedure using implantable targets

Described herein are devices for cleansing the internal surface of various body cavities. The devices generally include a handle and one or more cleansing tips having different sets of cleansing surfaces. In addition to removing debris, and disrupting bacterial biofilms so as to make these bacteria more susceptible to various cleansing agents, the devices may be configured to deliver an antiseptic agent, an anti-inflammatory agent, or a fragrance to the body cavity surfaces, or deliver UV light to sanitize the surfaces. Methods for cleansing the surfaces of body cavities such as the nasal passages and vaginal cavity are also described herein. Systems including one or more cleansing devices and one or more cleansing formulations are further described.

Personal cleansing wand

Tissue localization devices and methods of localizing tissue using tissue localization devices are disclosed. The tissue localization device can comprise a handle comprising a delivery control, a delivery needle extending out from the handle, and a localization element within the delivery needle. The localization element can be deployed out of the delivery needle or retracted back into the delivery needle when the delivery control is translated in a first direction or a second direction, respectively. The localization element can be coupled to a flexible tracking wire.

Tissue localization device and method of use thereof

Growing community of inventors

Palo Alto, CA, United States of America

Michael J Drews